Free provider profile
ELYSE RAYNEY, NP
Need more providers like ELYSE RAYNEY?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What ELYSE RAYNEY prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Ozempic
- Mounjaro
- Trulicity
- Jardiance
- Tresiba Flextouch U-200
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
802-730-2581
Practice address
173 WORCESTER ST, WELLESLEY, MA, 02481
- Registry updated
- 2023-01-02
- NPI issued
- 2017-03-11
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
173 WORCESTER ST, WELLESLEY, MA, 02481
802-730-2581
Single practice location
Enumerated 2017-03-11
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,744
Medicare patients
348
Part D drug cost
$1,259,650
Brand-name share
60.7%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ozempic (Semaglutide) | 167 | $278,068 |
| Trulicity (Dulaglutide) | 115 | $170,386 |
| Mounjaro (Tirzepatide) | 117 | $167,326 |
| Jardiance (Empagliflozin) | 93 | $132,981 |
| Tresiba Flextouch U-200 (Insulin Degludec) | 64 | $70,099 |
| Fiasp Flextouch (Insulin Aspart (Niacinamide)) | 60 | $66,130 |
| Humulin R U-500 Kwikpen (Insulin Regular, Human) | 14 | $57,454 |
| Toujeo Max Solostar (Insulin Glargine,hum.Rec.Anlog) | 30 | $42,496 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across MA — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
